Other

Deferred stock, issued (in shares)

Royalty Pharma Deferred stock, issued (in shares) increased by 3.9% to 427.4M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from 394.5M to 427.4M. Over 5 years (FY 2020 to FY 2025), Deferred stock, issued (in shares) shows an upward trend with a 5.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026
Metric ID: other_deferred_shares_shares_issued

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value355.2M357.7M361.2M363.5M365.3M369.3M371.3M376.4M382.5M382.8M384.6M388.9M390.1M390.5M392.3M394.5M409M409.9M411.5M427.4M
QoQ Change—+0.7%+1.0%+0.7%+0.5%+1.1%+0.6%+1.4%+1.6%+0.1%+0.5%+1.1%+0.3%+0.1%+0.4%+0.6%+3.7%+0.2%+0.4%+3.9%
YoY Change————+2.8%+3.2%+2.8%+3.6%+4.7%+3.7%+3.6%+3.3%+2.0%+2.0%+2.0%+1.4%+4.9%+5.0%+4.9%+8.3%
Range355.2M – 427.4M
CAGR+4.0%
Avg YoY Growth+3.6%
Median YoY Growth+3.4%
Current Streak19+ quarters growth

Frequently Asked Questions

What is Royalty Pharma's deferred stock, issued (in shares)?
Royalty Pharma (RPRX) reported deferred stock, issued (in shares) of 427.4M in Q1 2026.
How has Royalty Pharma's deferred stock, issued (in shares) changed year-over-year?
Royalty Pharma's deferred stock, issued (in shares) increased by 8.3% year-over-year, from 394.5M to 427.4M.
What is the long-term trend for Royalty Pharma's deferred stock, issued (in shares)?
Over 5 years (2020 to 2025), Royalty Pharma's deferred stock, issued (in shares) has grown at a 5.4% compound annual growth rate (CAGR), from 316.4M to 411.5M.